AI is rewriting drug discovery. Recursion Pharmaceuticals and Tempus AI might be the platforms that turn early investors into ...

Four years on from the devastating Lismore floods the disaster recovery program that followed is being wound down. Hundreds of millions of dollars have been spent on a house buyback program. And while ...

Pentagon's OPEN program to help set China-free minerals prices Four critical minerals to be AI model's first focus Program aims to help offset Chinese market interference Questions on how tariffs ...

All Nations Seventh-Day Adventist Church hosts March Gladness in Berrien Springs A church in Berrien Springs participated in March Madness with March Gladness combining basketball with a meaningful ...

Companies in the 8(a) small business contracting program are facing unprecedented pressure as the Trump administration paints it as rife with corruption and a bastion of illegal diversity, equity, and ...

The NASA Mars Sample Return program is encountering resistance from the planetary science community due to proposed budget language that would terminate the current mission framework. In early January ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

The T32 grant provides full-time research training support for post-candidacy predoctoral learners pursuing mentored clinical and translational research or clinical and translational science who are ...

I ran it 3 times after changing temperature to 1 for gpt-5-mini $ python examples/basic_usage.py Query: What were the key milestones in AI development according to ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...